Improving pandemic influenza risk assessment

Colin A. Russell, Peter M. Kasson, Ruben O. Donis, Steven Riley, John Dunbar, Andrew Rambaut, Jason Asher, Stephen Burke, C. Todd Davis, Rebecca J. Garten, Sandrasegaram Gnanakaran, Simon I. Hay, Sander Herfst, Nicola S. Lewis, James O. Lloyd-Smith, Catherine A. Macken, Sebastian Maurer-Stroh, Elizabeth Neuhaus, Colin R. Parrish, Kim M. PepinSamuel S. Shepard, David L. Smith, David L. Suarez, Susan C. Trock, Marc Alain Widdowson, Dylan B. George, Marc Lipsitch, Jesse D. Bloom

Research output: Contribution to journalArticlepeer-review

Abstract

Assessing the pandemic risk posed by specific non-human influenza A viruses is an important goal in public health research. As influenza virus genome sequencing becomes cheaper, faster, and more readily available, the ability to predict pandemic potential from sequence data could transform pandemic influenza risk assessment capabilities. However, the complexities of the relationships between virus genotype and phenotype make such predictions extremely difficult. The integration of experimental work, computational tool development, and analysis of evolutionary pathways, together with refinements to influenza surveillance, has the potential to transform our ability to assess the risks posed to humans by non-human influenza viruses and lead to improved pandemic preparedness and response.

Original languageEnglish (US)
Article numbere03883
Pages (from-to)e03883
JournaleLife
Volume3
DOIs
StatePublished - 2014

Keywords

  • emergence
  • evolutionary biology
  • genomics
  • human
  • infectious disease
  • influenza
  • microbiology
  • pandemic
  • viruses

ASJC Scopus subject areas

  • Neuroscience(all)
  • Immunology and Microbiology(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Improving pandemic influenza risk assessment'. Together they form a unique fingerprint.

Cite this